Notice Number: NOT-DK-18-002
Key Dates
Release Date: November 17, 2017
PAR-16-121
Issued by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Purpose
The purpose of the Notice is to change the remaining application due dates for PAR-16-121, "Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01)". Part I. Overview Information, Key Dates section of the FOA has been modified as follows:
Key Dates
Previously read:
Letter of Intent Due Dates (s)
30 days prior to the application due date
Application Due Date(s)
Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)
Not Applicable
Scientific Merit Review
Standard dates apply
Advisory Council Review
Standard dates apply
Earliest Start Date
Standard dates apply
Now reads:
Letter of Intent Due Dates (s)
February 12, 2018, June 12, 2018, October 12, 2018, and February 12, 2019
Application Due Date(s)
March 12, 2018, July 12, 2018, November 12, 2018, and March 12, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)
Not Applicable
Scientific Merit Review
June/July 2018, October/November 2018, February/March 2019, and June/July 2019.
Advisory Council Review
October 2018, January 2019, May 2019, and October 2019.
Earliest Start Date
December 2018, April 2019, July 2019, and December 2019.
All other aspects of this Funding Opportunity Announcement remain the same.
Inquiries
Please direct all inquiries to:
Aaron C. Pawlyk, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-451-7299
Email:[email protected]
and Human Services (HHS)
